Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonio Colombo, MD
Ospedale San Raffaele
Study Director - Azeem Latib, MD
Ospedale San Raffaele
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ospedale San Raffaele
Miano, Milano, Italy
- Ospedale Humanitas
Rozzano, Milano, Italy
- Policlinico San Donato
San Donato Milanese, Milano, Italy
- Azienda Ospedaliero Universitaria Policlinico Federico Ii
Naples, Italy
- Policlinico S. Matteo
Pavia, Italy
- Ospedale San Pietro, Fatebenefratelli
Roma, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2018
- Primary completion
- 15 Apr 2021
- Completion
- 26 Jul 2022
- Last update posted
- 27 Jul 2022
- Registered enrollment
- 137
- Registry id
- NCT03399994
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.